Two Days Versus Five Days of Postoperative Antibiotics for Complex Appendicitis: Cost Analysis of a Randomized, Noninferiority Trial
To compare costs for 2 days versus 5 days of postoperative antibiotics within the antibiotics after an aPPendectomy In Complex appendicitis trial.Background:Recent studies suggest that restrictive antibiotic use leads to a significant reduction in hospital stays without compromising patient safety....
Gespeichert in:
Veröffentlicht in: | Annals of surgery 2024-05, Vol.279 (5), p.885-890 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 890 |
---|---|
container_issue | 5 |
container_start_page | 885 |
container_title | Annals of surgery |
container_volume | 279 |
creator | de Wijkerslooth, Elisabeth M L Boerma, Evert-Jan G van Rossem, Charles C Koopmanschap, Marc A Baeten, Coen I M Beverdam, Frédérique H Bosmans, Joanna W A M Consten, Esther C J Dekker, Jan Willem T Emous, Marloes van Geloven, Anna A W Gijsen, Anton F Heijnen, Luc A Jairam, An P van der Ploeg, Augustinus P T Steenvoorde, Pascal Toorenvliet, Boudewijn R Vermaas, Maarten Wiering, Bas Wijnhoven, Bas P L van den Boom, Anne Loes |
description | To compare costs for 2 days versus 5 days of postoperative antibiotics within the antibiotics after an aPPendectomy In Complex appendicitis trial.Background:Recent studies suggest that restrictive antibiotic use leads to a significant reduction in hospital stays without compromising patient safety. Its potential effect on societal costs remains underexplored.
This was a pragmatic, open-label, multicenter clinical trial powered for noninferiority. Patients with complex appendicitis (age ≥ 8 years) were randomly allocated to 2 days or 5 days of intravenous antibiotics after appendectomy. Patient inclusion lasted from June 2017 to June 2021 in 15 Dutch hospitals. The final follow-up was on September 1, 2021. The primary trial endpoint was a composite endpoint of infectious complications and mortality within 90 days. In the present study, the main outcome measures were overall societal costs (comprising direct health care costs and costs related to productivity loss) and cost-effectiveness. Direct health care costs were recorded based on data in the electronic patient files, complemented by a telephone follow-up at 90 days. In addition, data on loss of productivity were acquired through the validated Productivity Cost Questionnaire at 4 weeks after surgery. Cost estimates were based on prices for the year 2019.
In total, 1005 patients were evaluated in the "intention-to-treat" analysis: 502 patients were allocated to the 2-day group and 503 to the 5-day group. The mean difference in overall societal costs was - €625 (95% CI: -€ 958 to -€ 278) to the advantage of the 2-day group. This difference was largely explained by reduced hospital stay. Productivity losses were similar between the study groups. Restricting postoperative antibiotics to 2 days was cost-effective, with estimated cost savings of €31,117 per additional infectious complication.
Two days of postoperative antibiotics for complex appendicitis results in a statistically significant and relevant cost reduction, as compared with 5 days. Findings apply to laparoscopic appendectomy in a well-resourced health care setting. |
doi_str_mv | 10.1097/SLA.0000000000006089 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_2864155787</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2864155787</sourcerecordid><originalsourceid>FETCH-LOGICAL-p126t-b5906cacb6e1ad698cb7091f85652f9b48b6813c246d3a6e29e5ab01ec0fec633</originalsourceid><addsrcrecordid>eNpNkMFKxDAURYMgzjj6ByJZurBj0jZp6q6MjgqDio5uS5q-QqRtapKqde2HW50RfJsLh8OF-xA6omROSZqcPa6yOfl3nIh0B00pC0VAaUwmaN-5F0JoLEiyhyZRwlNBQjZFX-t3gy_k4PAzWNc7vNRvsAGmwvfGedOBlf6HZq3XhTZeK4crY_HCNF0NHzjrOmhLrbTX7nykzo-qrAenf0skfpBtaRr9CeUpvjWtbiuw2ljtB7y2WtYHaLeStYPDbc7Q0_JyvbgOVndXN4tsFXQ05D4oWEq4kqrgQGU5LlBFQlJaCcZZWKVFLAouaKTCmJeR5BCmwGRBKChSgeJRNEMnm97OmtcenM8b7RTUtWzB9C4PBY8pY4lIRvV4q_ZFA2XeWd1IO-R_n4u-AYkqcRU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2864155787</pqid></control><display><type>article</type><title>Two Days Versus Five Days of Postoperative Antibiotics for Complex Appendicitis: Cost Analysis of a Randomized, Noninferiority Trial</title><source>MEDLINE</source><source>PubMed Central</source><source>Journals@Ovid Complete</source><creator>de Wijkerslooth, Elisabeth M L ; Boerma, Evert-Jan G ; van Rossem, Charles C ; Koopmanschap, Marc A ; Baeten, Coen I M ; Beverdam, Frédérique H ; Bosmans, Joanna W A M ; Consten, Esther C J ; Dekker, Jan Willem T ; Emous, Marloes ; van Geloven, Anna A W ; Gijsen, Anton F ; Heijnen, Luc A ; Jairam, An P ; van der Ploeg, Augustinus P T ; Steenvoorde, Pascal ; Toorenvliet, Boudewijn R ; Vermaas, Maarten ; Wiering, Bas ; Wijnhoven, Bas P L ; van den Boom, Anne Loes</creator><creatorcontrib>de Wijkerslooth, Elisabeth M L ; Boerma, Evert-Jan G ; van Rossem, Charles C ; Koopmanschap, Marc A ; Baeten, Coen I M ; Beverdam, Frédérique H ; Bosmans, Joanna W A M ; Consten, Esther C J ; Dekker, Jan Willem T ; Emous, Marloes ; van Geloven, Anna A W ; Gijsen, Anton F ; Heijnen, Luc A ; Jairam, An P ; van der Ploeg, Augustinus P T ; Steenvoorde, Pascal ; Toorenvliet, Boudewijn R ; Vermaas, Maarten ; Wiering, Bas ; Wijnhoven, Bas P L ; van den Boom, Anne Loes ; APPIC Study Group</creatorcontrib><description>To compare costs for 2 days versus 5 days of postoperative antibiotics within the antibiotics after an aPPendectomy In Complex appendicitis trial.Background:Recent studies suggest that restrictive antibiotic use leads to a significant reduction in hospital stays without compromising patient safety. Its potential effect on societal costs remains underexplored.
This was a pragmatic, open-label, multicenter clinical trial powered for noninferiority. Patients with complex appendicitis (age ≥ 8 years) were randomly allocated to 2 days or 5 days of intravenous antibiotics after appendectomy. Patient inclusion lasted from June 2017 to June 2021 in 15 Dutch hospitals. The final follow-up was on September 1, 2021. The primary trial endpoint was a composite endpoint of infectious complications and mortality within 90 days. In the present study, the main outcome measures were overall societal costs (comprising direct health care costs and costs related to productivity loss) and cost-effectiveness. Direct health care costs were recorded based on data in the electronic patient files, complemented by a telephone follow-up at 90 days. In addition, data on loss of productivity were acquired through the validated Productivity Cost Questionnaire at 4 weeks after surgery. Cost estimates were based on prices for the year 2019.
In total, 1005 patients were evaluated in the "intention-to-treat" analysis: 502 patients were allocated to the 2-day group and 503 to the 5-day group. The mean difference in overall societal costs was - €625 (95% CI: -€ 958 to -€ 278) to the advantage of the 2-day group. This difference was largely explained by reduced hospital stay. Productivity losses were similar between the study groups. Restricting postoperative antibiotics to 2 days was cost-effective, with estimated cost savings of €31,117 per additional infectious complication.
Two days of postoperative antibiotics for complex appendicitis results in a statistically significant and relevant cost reduction, as compared with 5 days. Findings apply to laparoscopic appendectomy in a well-resourced health care setting.</description><identifier>EISSN: 1528-1140</identifier><identifier>DOI: 10.1097/SLA.0000000000006089</identifier><identifier>PMID: 37698025</identifier><language>eng</language><publisher>United States</publisher><subject>Anti-Bacterial Agents - therapeutic use ; Appendectomy - methods ; Appendicitis - drug therapy ; Appendicitis - surgery ; Child ; Health Care Costs ; Humans ; Length of Stay ; Treatment Outcome</subject><ispartof>Annals of surgery, 2024-05, Vol.279 (5), p.885-890</ispartof><rights>Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37698025$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>de Wijkerslooth, Elisabeth M L</creatorcontrib><creatorcontrib>Boerma, Evert-Jan G</creatorcontrib><creatorcontrib>van Rossem, Charles C</creatorcontrib><creatorcontrib>Koopmanschap, Marc A</creatorcontrib><creatorcontrib>Baeten, Coen I M</creatorcontrib><creatorcontrib>Beverdam, Frédérique H</creatorcontrib><creatorcontrib>Bosmans, Joanna W A M</creatorcontrib><creatorcontrib>Consten, Esther C J</creatorcontrib><creatorcontrib>Dekker, Jan Willem T</creatorcontrib><creatorcontrib>Emous, Marloes</creatorcontrib><creatorcontrib>van Geloven, Anna A W</creatorcontrib><creatorcontrib>Gijsen, Anton F</creatorcontrib><creatorcontrib>Heijnen, Luc A</creatorcontrib><creatorcontrib>Jairam, An P</creatorcontrib><creatorcontrib>van der Ploeg, Augustinus P T</creatorcontrib><creatorcontrib>Steenvoorde, Pascal</creatorcontrib><creatorcontrib>Toorenvliet, Boudewijn R</creatorcontrib><creatorcontrib>Vermaas, Maarten</creatorcontrib><creatorcontrib>Wiering, Bas</creatorcontrib><creatorcontrib>Wijnhoven, Bas P L</creatorcontrib><creatorcontrib>van den Boom, Anne Loes</creatorcontrib><creatorcontrib>APPIC Study Group</creatorcontrib><title>Two Days Versus Five Days of Postoperative Antibiotics for Complex Appendicitis: Cost Analysis of a Randomized, Noninferiority Trial</title><title>Annals of surgery</title><addtitle>Ann Surg</addtitle><description>To compare costs for 2 days versus 5 days of postoperative antibiotics within the antibiotics after an aPPendectomy In Complex appendicitis trial.Background:Recent studies suggest that restrictive antibiotic use leads to a significant reduction in hospital stays without compromising patient safety. Its potential effect on societal costs remains underexplored.
This was a pragmatic, open-label, multicenter clinical trial powered for noninferiority. Patients with complex appendicitis (age ≥ 8 years) were randomly allocated to 2 days or 5 days of intravenous antibiotics after appendectomy. Patient inclusion lasted from June 2017 to June 2021 in 15 Dutch hospitals. The final follow-up was on September 1, 2021. The primary trial endpoint was a composite endpoint of infectious complications and mortality within 90 days. In the present study, the main outcome measures were overall societal costs (comprising direct health care costs and costs related to productivity loss) and cost-effectiveness. Direct health care costs were recorded based on data in the electronic patient files, complemented by a telephone follow-up at 90 days. In addition, data on loss of productivity were acquired through the validated Productivity Cost Questionnaire at 4 weeks after surgery. Cost estimates were based on prices for the year 2019.
In total, 1005 patients were evaluated in the "intention-to-treat" analysis: 502 patients were allocated to the 2-day group and 503 to the 5-day group. The mean difference in overall societal costs was - €625 (95% CI: -€ 958 to -€ 278) to the advantage of the 2-day group. This difference was largely explained by reduced hospital stay. Productivity losses were similar between the study groups. Restricting postoperative antibiotics to 2 days was cost-effective, with estimated cost savings of €31,117 per additional infectious complication.
Two days of postoperative antibiotics for complex appendicitis results in a statistically significant and relevant cost reduction, as compared with 5 days. Findings apply to laparoscopic appendectomy in a well-resourced health care setting.</description><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Appendectomy - methods</subject><subject>Appendicitis - drug therapy</subject><subject>Appendicitis - surgery</subject><subject>Child</subject><subject>Health Care Costs</subject><subject>Humans</subject><subject>Length of Stay</subject><subject>Treatment Outcome</subject><issn>1528-1140</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpNkMFKxDAURYMgzjj6ByJZurBj0jZp6q6MjgqDio5uS5q-QqRtapKqde2HW50RfJsLh8OF-xA6omROSZqcPa6yOfl3nIh0B00pC0VAaUwmaN-5F0JoLEiyhyZRwlNBQjZFX-t3gy_k4PAzWNc7vNRvsAGmwvfGedOBlf6HZq3XhTZeK4crY_HCNF0NHzjrOmhLrbTX7nykzo-qrAenf0skfpBtaRr9CeUpvjWtbiuw2ljtB7y2WtYHaLeStYPDbc7Q0_JyvbgOVndXN4tsFXQ05D4oWEq4kqrgQGU5LlBFQlJaCcZZWKVFLAouaKTCmJeR5BCmwGRBKChSgeJRNEMnm97OmtcenM8b7RTUtWzB9C4PBY8pY4lIRvV4q_ZFA2XeWd1IO-R_n4u-AYkqcRU</recordid><startdate>20240501</startdate><enddate>20240501</enddate><creator>de Wijkerslooth, Elisabeth M L</creator><creator>Boerma, Evert-Jan G</creator><creator>van Rossem, Charles C</creator><creator>Koopmanschap, Marc A</creator><creator>Baeten, Coen I M</creator><creator>Beverdam, Frédérique H</creator><creator>Bosmans, Joanna W A M</creator><creator>Consten, Esther C J</creator><creator>Dekker, Jan Willem T</creator><creator>Emous, Marloes</creator><creator>van Geloven, Anna A W</creator><creator>Gijsen, Anton F</creator><creator>Heijnen, Luc A</creator><creator>Jairam, An P</creator><creator>van der Ploeg, Augustinus P T</creator><creator>Steenvoorde, Pascal</creator><creator>Toorenvliet, Boudewijn R</creator><creator>Vermaas, Maarten</creator><creator>Wiering, Bas</creator><creator>Wijnhoven, Bas P L</creator><creator>van den Boom, Anne Loes</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>20240501</creationdate><title>Two Days Versus Five Days of Postoperative Antibiotics for Complex Appendicitis: Cost Analysis of a Randomized, Noninferiority Trial</title><author>de Wijkerslooth, Elisabeth M L ; Boerma, Evert-Jan G ; van Rossem, Charles C ; Koopmanschap, Marc A ; Baeten, Coen I M ; Beverdam, Frédérique H ; Bosmans, Joanna W A M ; Consten, Esther C J ; Dekker, Jan Willem T ; Emous, Marloes ; van Geloven, Anna A W ; Gijsen, Anton F ; Heijnen, Luc A ; Jairam, An P ; van der Ploeg, Augustinus P T ; Steenvoorde, Pascal ; Toorenvliet, Boudewijn R ; Vermaas, Maarten ; Wiering, Bas ; Wijnhoven, Bas P L ; van den Boom, Anne Loes</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p126t-b5906cacb6e1ad698cb7091f85652f9b48b6813c246d3a6e29e5ab01ec0fec633</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Appendectomy - methods</topic><topic>Appendicitis - drug therapy</topic><topic>Appendicitis - surgery</topic><topic>Child</topic><topic>Health Care Costs</topic><topic>Humans</topic><topic>Length of Stay</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>de Wijkerslooth, Elisabeth M L</creatorcontrib><creatorcontrib>Boerma, Evert-Jan G</creatorcontrib><creatorcontrib>van Rossem, Charles C</creatorcontrib><creatorcontrib>Koopmanschap, Marc A</creatorcontrib><creatorcontrib>Baeten, Coen I M</creatorcontrib><creatorcontrib>Beverdam, Frédérique H</creatorcontrib><creatorcontrib>Bosmans, Joanna W A M</creatorcontrib><creatorcontrib>Consten, Esther C J</creatorcontrib><creatorcontrib>Dekker, Jan Willem T</creatorcontrib><creatorcontrib>Emous, Marloes</creatorcontrib><creatorcontrib>van Geloven, Anna A W</creatorcontrib><creatorcontrib>Gijsen, Anton F</creatorcontrib><creatorcontrib>Heijnen, Luc A</creatorcontrib><creatorcontrib>Jairam, An P</creatorcontrib><creatorcontrib>van der Ploeg, Augustinus P T</creatorcontrib><creatorcontrib>Steenvoorde, Pascal</creatorcontrib><creatorcontrib>Toorenvliet, Boudewijn R</creatorcontrib><creatorcontrib>Vermaas, Maarten</creatorcontrib><creatorcontrib>Wiering, Bas</creatorcontrib><creatorcontrib>Wijnhoven, Bas P L</creatorcontrib><creatorcontrib>van den Boom, Anne Loes</creatorcontrib><creatorcontrib>APPIC Study Group</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Annals of surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>de Wijkerslooth, Elisabeth M L</au><au>Boerma, Evert-Jan G</au><au>van Rossem, Charles C</au><au>Koopmanschap, Marc A</au><au>Baeten, Coen I M</au><au>Beverdam, Frédérique H</au><au>Bosmans, Joanna W A M</au><au>Consten, Esther C J</au><au>Dekker, Jan Willem T</au><au>Emous, Marloes</au><au>van Geloven, Anna A W</au><au>Gijsen, Anton F</au><au>Heijnen, Luc A</au><au>Jairam, An P</au><au>van der Ploeg, Augustinus P T</au><au>Steenvoorde, Pascal</au><au>Toorenvliet, Boudewijn R</au><au>Vermaas, Maarten</au><au>Wiering, Bas</au><au>Wijnhoven, Bas P L</au><au>van den Boom, Anne Loes</au><aucorp>APPIC Study Group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Two Days Versus Five Days of Postoperative Antibiotics for Complex Appendicitis: Cost Analysis of a Randomized, Noninferiority Trial</atitle><jtitle>Annals of surgery</jtitle><addtitle>Ann Surg</addtitle><date>2024-05-01</date><risdate>2024</risdate><volume>279</volume><issue>5</issue><spage>885</spage><epage>890</epage><pages>885-890</pages><eissn>1528-1140</eissn><abstract>To compare costs for 2 days versus 5 days of postoperative antibiotics within the antibiotics after an aPPendectomy In Complex appendicitis trial.Background:Recent studies suggest that restrictive antibiotic use leads to a significant reduction in hospital stays without compromising patient safety. Its potential effect on societal costs remains underexplored.
This was a pragmatic, open-label, multicenter clinical trial powered for noninferiority. Patients with complex appendicitis (age ≥ 8 years) were randomly allocated to 2 days or 5 days of intravenous antibiotics after appendectomy. Patient inclusion lasted from June 2017 to June 2021 in 15 Dutch hospitals. The final follow-up was on September 1, 2021. The primary trial endpoint was a composite endpoint of infectious complications and mortality within 90 days. In the present study, the main outcome measures were overall societal costs (comprising direct health care costs and costs related to productivity loss) and cost-effectiveness. Direct health care costs were recorded based on data in the electronic patient files, complemented by a telephone follow-up at 90 days. In addition, data on loss of productivity were acquired through the validated Productivity Cost Questionnaire at 4 weeks after surgery. Cost estimates were based on prices for the year 2019.
In total, 1005 patients were evaluated in the "intention-to-treat" analysis: 502 patients were allocated to the 2-day group and 503 to the 5-day group. The mean difference in overall societal costs was - €625 (95% CI: -€ 958 to -€ 278) to the advantage of the 2-day group. This difference was largely explained by reduced hospital stay. Productivity losses were similar between the study groups. Restricting postoperative antibiotics to 2 days was cost-effective, with estimated cost savings of €31,117 per additional infectious complication.
Two days of postoperative antibiotics for complex appendicitis results in a statistically significant and relevant cost reduction, as compared with 5 days. Findings apply to laparoscopic appendectomy in a well-resourced health care setting.</abstract><cop>United States</cop><pmid>37698025</pmid><doi>10.1097/SLA.0000000000006089</doi><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | EISSN: 1528-1140 |
ispartof | Annals of surgery, 2024-05, Vol.279 (5), p.885-890 |
issn | 1528-1140 |
language | eng |
recordid | cdi_proquest_miscellaneous_2864155787 |
source | MEDLINE; PubMed Central; Journals@Ovid Complete |
subjects | Anti-Bacterial Agents - therapeutic use Appendectomy - methods Appendicitis - drug therapy Appendicitis - surgery Child Health Care Costs Humans Length of Stay Treatment Outcome |
title | Two Days Versus Five Days of Postoperative Antibiotics for Complex Appendicitis: Cost Analysis of a Randomized, Noninferiority Trial |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-15T16%3A25%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Two%20Days%20Versus%20Five%20Days%20of%20Postoperative%20Antibiotics%20for%20Complex%20Appendicitis:%20Cost%20Analysis%20of%20a%20Randomized,%20Noninferiority%20Trial&rft.jtitle=Annals%20of%20surgery&rft.au=de%20Wijkerslooth,%20Elisabeth%20M%20L&rft.aucorp=APPIC%20Study%20Group&rft.date=2024-05-01&rft.volume=279&rft.issue=5&rft.spage=885&rft.epage=890&rft.pages=885-890&rft.eissn=1528-1140&rft_id=info:doi/10.1097/SLA.0000000000006089&rft_dat=%3Cproquest_pubme%3E2864155787%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2864155787&rft_id=info:pmid/37698025&rfr_iscdi=true |